Qualigen Therapeutics, Inc. (QLGN)
NASDAQ: QLGN · Real-Time Price · USD
0.105
-0.007 (-6.42%)
At close: Oct 29, 2024, 4:00 PM
0.104
-0.001 (-0.95%)
After-hours: Oct 29, 2024, 7:58 PM EDT
Qualigen Therapeutics Market Cap
Qualigen Therapeutics has a market cap or net worth of $2.84 million as of October 29, 2024. Its market cap has decreased by -39.63% in one year.
Market Cap
2.84M
Enterprise Value
4.58M
1-Year Change
-39.63%
Ranking
Category
Stock Price
$0.11
Market Cap Chart
Since June 24, 2015, Qualigen Therapeutics's market cap has decreased from $38.60M to $2.84M, a decrease of -92.65%. That is a compound annual growth rate of -24.35%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 28, 2024 | 1.40M | -50.00% |
| Dec 29, 2023 | 2.80M | -48.15% |
| Dec 30, 2022 | 5.40M | -82.69% |
| Dec 31, 2021 | 31.20M | -55.04% |
| Dec 31, 2020 | 69.40M | 3,982.35% |
| Dec 31, 2019 | 1.70M | -50.00% |
| Dec 31, 2018 | 3.40M | -79.14% |
| Dec 29, 2017 | 16.30M | -43.99% |
| Dec 30, 2016 | 29.10M | 120.45% |
| Dec 31, 2015 | 13.20M | -65.80% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Scinai Immunotherapeutics | 3.00M |
| Molecular Templates | 2.96M |
| Sonnet BioTherapeutics Holdings | 2.93M |
| Bone Biologics | 2.91M |
| Protagenic Therapeutics | 2.85M |
| Phio Pharmaceuticals | 2.83M |
| iSpecimen | 2.76M |
| Heart Test Laboratories | 2.73M |